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Abstract
Background: Surgery for benign disease is associated with a low-risk of developing venous thromboembolism
(VTE). Despite a relatively low incidence of postoperative VTE in patients after elective cholecystectomy and
abdominal hernia repair there are data proving hypercoagulability in the early postoperative period. We focused on
assessment of the systemic inflammatory response and coagulation status in these surgical patients after hospital
discharge.
Methods: Prospectively, patients who underwent surgery for benign disease were included. Two hundred sixteen
patients were enrolled - 90 patients in laparoscopic cholecystectomy (LC) group and 126 patients in hernia surgery
(HS) group. Risk assessment of VTE according to the Caprini risk assessment model was performed in all patients.
Prevalence of VTE in postoperative period was observed. Markers of systemic inflammatory response (IL-6, CRP,
α-1-acid glycoprotein, transferrin) and coagulation markers (PLT, fibrinogen, prothrombin fragment F1 + 2 and
D-dimer) were measured before surgery, on 7–10th postoperative day and on 28–30th postoperative day.
Results: Clinically apparent deep vein thrombosis was diagnosed in only one patient - 0.46 %. Statistically
significant elevation of inflammatory markers IL-6, CRP and α-1-acid glycoprotein (p < 0.001; all) were proved in
both groups of patients on 7–10th postoperative day. Statistically significant elevation of coagulation markers PLT,
fibrinogen, prothrombin fragment F1 + 2 and D-dimer (p < 0.001; all) were proved in LC and HS groups on 7–10th
postoperative day. No statistical difference was observed in IL-6, CRP and α-1-acid glycoprotein levels a month after
surgery as compared with preoperative levels within each group. Statistically significant elevation of fibrinogen and
prothrombin fragment F1 + 2 levels (p < 0.001; both) persisted on 28–30th postoperative day in both groups. Persisted
elevation of D-dimer levels was proved only in HS group (p < 0.001), not in LC group (p = 0.138), a month after surgery.
Conclusions: Activated systemic inflammatory response and hypercoagulable condition were verified in patients after
laparoscopic cholecystectomy and hernia surgery after their hospital discharge. Hypercoagulability persisted even a
month after surgery. Nevertheless, we observed very low prevalence of clinically apparent VTE in patients with
in-hospital postoperative VTE prophylaxis.
Trial registration: Trials of the Czech Ministry of Health No. RVO-VFN64165 and NT 13251-4.
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Background
Abdominal hernia repair, cholecystectomy and varicose
vein operation have been considered as low-risk surgery
for developing venous thromboembolism (VTE). In the
literature, the reported incidence of VTE ranges from
0.08 %–1.2 % in patients undergoing hernia repair,
0.28 %–0.53 % in patients after elective laparoscopic
cholecystectomy and 0.18 % in patients after varicose
vein operation [1–4]. The risk of VTE is usually deter-
mined according to the Caprini risk assessment model.
Routine pharmacologic prophylaxis of VTE in general
surgery is recommended only for moderate and high risk
patients [5]. In patients with very low and low risk of
VTE only, early mobilisation and/or mechanical prophy-
laxis of VTE (elastic compression stockings) is recom-
mended [5]. There is no recommendation in the 9th
ACCP guidelines regarding the duration of VTE prophy-
laxis in surgery for benign diseases and no definite con-
sensus exists because of the absence of sufficient
numbers of valid data. Postoperative prophylaxis in dur-
ation of 7–10 days or VTE prophylaxis until full mobil-
isation of the patient is recommended most frequently
in low risk surgery [6]. Some authors demonstrate the
feasibility of short postoperative VTE prophylaxis with-
out higher rates of venous thromboembolism. They rec-
ommend individualised duration of VTE prophylaxis
administration based on stratification of the VTE risk in
concrete patients [7, 8]. Despite relatively low incidences
of postoperative VTE in patients after elective chole-
cystectomy and abdominal hernia repair, there are
data proving hypercoagulability in the early postoper-
ative period. Hypercoagulable status in patients after
elective laparoscopic and open surgery has been well-
documented in numerous publications [9–11]. How-
ever, most of the previous studies have monitored
coagulation status and systemic inflammatory re-
sponse only in the early postoperative period, most
often within 72 h after surgery [9–17]. We focused
on assessment of the systemic inflammatory response
and coagulation status in patients after open hernia
repair and after laparoscopic cholecystectomy one
week and one month after surgery, when these pa-
tients were already predominantly out-of-hospital. The
patients were compared with the grade of thrombo-
embolic risk according to a new adaptation of the
Caprini risk assessment model [5].
Methods
Patients
The study was performed as a prospective nonrando-
mized study from January 2011 to April 2012 and the
patients undergoing surgery for benign diseases were
included. Altogether 232 consecutive patients were
enrolled in our study. 16 patients were dropped out
because of incomplete laboratory tests. Thus, we assessed
216 patients, of whom 90 patients underwent a laparo-
scopic cholecystectomy (LC) and 126 patients underwent
an elective abdominal hernia surgery (HS). Inclusion
criteria: elective laparoscopic surgery for symptomatic
gall stone disease or elective open surgery for abdominal
hernia. Exclusion criteria: acute cholecystitis, incarcerated
hernia, age < 18 or > 90 years, malignancy, VTE in previ-
ous 6 months. Basic clinical parameters – age, height,
weight, body mass index (BMI), blood pressure, pulse –
were noted in every patient. A new adaptation of the
Caprini risk assessment model was used to assess the VTE
risk in every patient preoperatively [5]. Each patient was
classified into one of four risk groups – very low risk, low
risk, moderate risk and high risk. VTE prophylaxis
comprised the use of lower extremity bandages and
administration of low-molecular-weight heparin (LMWH)
subcutaneously. LMWH was administered once a day up
to the hospital discharge or full mobilisation of the patient.
In the postoperative period, clinical parameters were ob-
served – length of hospital stay, duration of LMWH ad-
ministration, postoperative complications and clinically
apparent VTE in 30 days’ postoperative period. Postopera-
tive complications were assessed according to Clavien-
Dindo classification [18]. Clinical assessment of deep vein
thrombosis risk was performed according to the Wells
score system [19]. Patients with a Wells score of > 2 war-
rant ultrasound examination of legs to verify deep vein
thrombosis. Genetic examination was carried out in all
patients to exclude hereditary thrombophilia – Factor V
Leiden mutation (FVL) and factor II – prothrombin
20210G >A mutation. For monitoring of systemic inflam-
matory response, these markers were used: interleukin 6
(IL-6), C-reactive protein (CRP), α-1-acid glycoprotein
(Oroso), transferrin (Trf). For monitoring of postoperative
hypercoagulability, these markers were used: platelets
count (PLT), fibrinogen (Fbg), prothrombin fragment
F1 + 2 (F1 + 2) and D-dimer. Markers of systemic in-
flammatory response and coagulation markers were
measured preoperatively, on 7-10th postoperative day
and on 28–30th postoperative day. The study was ap-
proved by the ethics committee of the 1st Faculty of
Medicine of Charles University and General University
Hospital in Prague. Each participant gave written in-
formed consent to be included in the study and with the
anonymous publication of data.
Laboratory tests
Venous blood samples were obtained and adminis-
tered to Vacutainer™ pneumatic tubes (Becton Dickinson,
Meylan Cedex, France). EDTA blood was used for full
blood count. Hemogram was determined with Beckman
Coulter UniCel®DxH800 Cellular Analysis System
(Beckman Coulter, Miami, Florida, USA). Citrated platelet
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poor plasma was prepared by double centrifugation at
2500 × g for 15 min at room temperature and stored in
1.0 mL aliquots at − 80 °C until testing fibrinogen, pro-
thrombin fragment F1 + F2 and D-dimer. Coagulation
tests were carried out on a Behring coagulation system
(BCS) ™ analyzer (Dade Behring, Marburg, Germany). De-
termination of F IIa (trombin) inhibition and concentra-
tion level of prothrombin fragment F1 + 2 were carried
out according to the manufacturer‘s instructions using the
MRX Microplate Reader™ microphotometer (Dynatech
Laboratories, Chantilly, USA). Fibrinogen was determined
using the Fibrinogen reagent kit (product supplied By
Technoclone, Austria). Prothrombin fragment F1 + 2 was
determined using the Enzygnost® F 1 + 2 micro kit
(product supplied by Dade Behring, Marburg, Germany).
D-dimer was determined using the ELISA D dimer kit
(product supplied by Boehring-Mannheim, Germany).
Acute phase proteins (CRP, Oroso, Trf) were determined
using the Nephelometer BNII (Dade Behring, Marburg,
Germany).
Genetic tests
Genome DNA was extracted from leukocytes in per-
ipheral blood and isolated using the MagNA Pure LC
Nucleic Acid Extraction system™ with a MagNA Pure
DNA Isolation Kit I™. DNA was isolated according to
the MagNA Pure High-Performance DNA Extraction™
protocol (all products supplied by Roche Diagnostics,
Mannheim, Germany). Monitored mutations were deter-
mined using PCR in a process called FRET (Fluorescence
Resonance Energy Transfer). Tests were performed using
the LightCycler® 480 System with LC® 480 Genotyping
Master kits (all products supplied by Roche Diagnostics,
Mannheim, Germany). Specific primers and fluorescently
labelled probes were designed in cooperation with TIB
MOLBIOL (Berlin, Germany), where they were custom
made.
Statistical analysis
Basic descriptive statistics within two groups of patients
(cholecystectomy, hernia repair) were computed for all
variables, which were subsequently tested for normality
using Kolmogorov-Smirnov and Shapiro-Wilk tests.
Changes in the non-normally distributed systemic in-
flammatory response markers (IL6, CRP, Oroso, Trf )
and coagulant markers (Fbg, D-dimer, PLT, F1 + F2)
at three different time points (preoperative, 1 week after
surgery and 4 weeks after surgery) were assessed separ-
ately within each group of patients by the Friedmann test,
followed by a series of Wilcoxon signed rank tests with
Bonferroni correction as a post-hoc comparison. P-values
below 0.05 were considered to be statistically significant.
Statistical analysis was performed using SPSS version 22
(SPSS Inc., Chicago, IL, USA).
Results
Basic characteristics of our study group
Basic characteristics of our study group are depicted in
Table 1. Only patients with uncomplicated symptomatic
gallstone disease were included in LC group. All chole-
cystectomies were finished laparoscopically. The hernia
surgery group comprises patients with different types of
abdominal hernias – inguinal hernia n = 65 (51.59 %), in-
cisional hernia n = 26 (20.63 %), umbilical hernia n = 17
(13.49 %), epigastric hernia n = 17 (13.49 %), femoral
hernia n = 1 (0.79 %). Hernia repair was performed either
as a conventional open hernioplasty n = 95 (75.40 %) or
open hernia repair with mesh n = 31 (24.60 %). Risk as-
sessment of VTE in the study population, as per the
Caprini risk assessment model, is shown in Table 2.
Postoperative course
The median length of postoperative hospital stay for
both groups was 3 days. Equally, the median length of
LMWH administration for patients was 3 days after both
types of surgery. Postoperative complications occurred
in 6 patients (2.78 %) - wound hematoma n = 4 (1.85 %),
postoperative bronchopneumonia n = 1 (0.46 %), clinic-
ally apparent deep vein thrombosis n = 1 (0.46 %). Clas-
sification of postoperative complications is shown in
Table 3.
Hereditary trombophilia
Hereditary thrombophilia was detected in 18 patients
(8.33 %) – FVL mutation (heterozygote) in 11 patients
(5.12 %), Factor II 20210G > A mutation (heterozygote)
in 6 patients (2.80 %) and, in one patient, both muta-
tions (FVL and F II 20210G > A heterozygote) were
proved. The hereditary thrombophilic status was diag-
nosed in 8 patients (8.89 %) in LC group and in 10 pa-
tients (7.94 %) in HS group.
Acute phase proteins and coagulation markers
Hernia surgery group
On postoperative day 7–10, statistically significant ele-
vation of most acute phase proteins were proved as
Table 1 Basic characteristics of study population
Cholecystectomy Hernia surgery
Median (IQR) Median (IQR)
Age (years) 53.00 (38.00 – 61.25) 58.00 (41.50 – 66.00)
Height (cm) 168.50 (164.75 – 176.50) 175.00 (170.00 – 180.00)
Weight (kg) 75.00 (63.00 – 85.00) 84.00 (74.00 – 92.50)
BMI (kg/m2) 26.15 (22.75 – 28.45) 27.00 (24.75 – 29.90)
BP syst. (mmHg) 120.00 (120.00 – 130.00) 120.00 (120.00 – 135.00)
BP diast. (mmHg) 80.00 (78.75 – 80.00) 80.00 (75.00 – 80.00)
Puls (/min.) 75.00 (69.50 – 76.00) 76.00 (70.00 – 76.00)
Notes: IQR interquartile range; BMI body mass index; BP blood pressure
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compared to preoperative levels - IL-6 (p < 0.001), CRP
(p < 0.001) and α-1-acid glycoprotein (p < 0.001). Trans-
ferrin levels did not differ significantly (p = 0.074). On
day 28–30 after surgery, no significant difference in
levels of IL-6 (p = 0.281), CRP (p = 0.267) and α-1-acid
glycoprotein (p = 0.527) were observed as compared
with preoperative levels; however, transferrin signifi-
cantly decreased compared to the preoperative levels
(p = 0.001). A statistically significant increase in coagu-
lation marker levels was proved on day 7–10 after sur-
gery – PLT, fibrinogen, prothrombin fragment F1 + 2
and D-dimer (p < 0.001; all). On postoperative day 28-
30, only PLT levels did not differ significantly compared
to preoperative PLT levels (p = 0.088). Persisted eleva-
tion of fibrinogen, prothrombin fragment F1 + 2 and D-
dimer levels (p < 0.001, all) were observed even one
month after hernia surgery (Table 4).
Laparoscopic cholecystectomy group
On postoperative day 7–10, statistically significant eleva-
tion of acute phase proteins were proved as compared to
preoperative levels - IL-6 (p = 0.002), CRP (p < 0.001)
and α-1-acid glycoprotein (p < 0.001). Transferrin levels
did not differ significantly (p = 0.057). On day 28–30
after surgery, no significant difference in levels of IL-6
(p = 0.865), CRP (p = 0.074) and α-1-acid glycoprotein
(p = 0.201) were observed as compared with preopera-
tive levels; however, transferrin significantly decreased
compared to the preoperative levels (p = 0.007). A sta-
tistically significant increase in coagulation marker
levels was proved on day 7–10 after surgery – PLT,
fibrinogen, prothrombin fragment F1 + 2 and D-dimer
(p < 0.001; all). On postoperative day 28–30, PLT levels
(p = 0.042) and D-dimer levels (p = 0.138) did not differ
significantly compared to preoperative levels. However,
persisted elevation of fibrinogen, prothrombin fragment
F1 + 2 levels (p = 0.002; both) were observed even one
month after laparoscopic cholecystectomy (Table 4).
Discussion
Given the absence of data related to the duration of
postoperative systemic inflammatory response and post-
operative hypercoagulability in patients after surgery for
benign disease, we focused on the monitoring of inflam-
matory markers and coagulation markers in patients
after open hernia surgery (HS) and after laparoscopic
cholecystectomy (LC). Basic characteristics of the study
population were assessed separately for more detailed in-
formation, not for comparison. Most patients in the HS
group and LC group were classified as moderate risk
(47.6 % and 43.3 %, respectively) and high risk (38.9 %
and 47.8 %, respectively) according to the new adapta-
tion of the Caprini risk assessment model. The postoper-
ative risk of VTE can also be increased by hereditary
thrombophilia and postoperative complications. FVL
and Factor II 20210G > A belong among the most fre-
quent hereditary thrombophilia predispositions with a
moderate risk of VTE. The frequency of these two
hereditary thrombophilic conditions in our study popu-
lation corresponds to their prevalence in the Czech
population [20]. Postoperative complications are an im-
portant factor which can affect postoperative systemic
inflammatory response and prolong postoperative hyper-
coagulability. The postoperative complications were
acceptably low in our study group. Just et al. reported a
complication rate of 2.7 % after hernia surgery and
Ahmad et al. reported a complication rate of 5.4 % after
laparoscopic cholecystectomy [21, 22]. The median
length of LMWH administration is identical to the me-
dian length of hospital stay (3 days). This fact corre-
sponds with the generally performed clinical practice of
administering pharmacologic VTE prophylaxis only in
hospital. There is no definite recommendation concern-
ing the length of administration of pharmacologic VTE
Table 2 Classification of VTE risk in study population according
to the Caprini risk assessment model
Patient stratification Cholecystectomy
no. of pts. (%)
Hernia surgery
no. of pts. (%)
Very low risk (0 point) 0 0
Low risk (1–2 points) 8 (8.9 %) 17 (13.5 %)
Moderate risk (3–4 points) 39 (43.3 %) 60 (47.6 %)
High risk (>5 points) 43 (47.8 %) 49 (38.9 %)
Table 3 Postoperative course and postoperative complications
Cholecystectomy Hernia surgery
Postoperative complications according to
Clavien-Dindo classification (No. of pts.)
Clavien-Dindo II Postoperative pneumonia (n = 1) Wound hematoma (n = 2) DVT (n = 1)
Clavien-Dindo IIIa Wound hematoma (n = 1)
Clavien-Dindo IIIb Wound hematoma (n = 1)
Length of hospital stay, days median (range) 3 (2–9) 3 (1–10)
Length of LMWH administration, days median (range) 3 (1–9) 3 (1–10)
Notes: DVT deep vein thrombosis; LMWH low molecular weight heparin
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prophylaxis in patients operated on for benign diseases.
Tincani et al. published a study in which they observed
the prevalence of postoperative VTE in patients
undergoing laparoscopic surgery for a benign disease
and compared the two different pharmacologic
thromboprophylaxis regimens; a short-term pharma-
cologic thromboprophylaxis (3–4 days in hospital) or
an extended-duration pharmacologic thromboprophy-
laxis (in hospital + 7 days after discharge). The preva-
lence of deep vein thrombosis in patients with the
short-term VTE prophylaxis was 0.95 % and the
authors concluded that the extended-duration VTE
prophylaxis did not provide any benefit [7]. Our re-
sults (prevalence of postoperative VTE in our study
population – 0.46 %) support the conclusion that in
patients undergoing an uncomplicated surgery for a
benign disease, the risk of clinically apparent VTE
after hospital discharge is very low (in the case of
correct VTE prophylaxis in hospital).
Surgery is associated with the development of a stress
reaction by the organism which is called systemic in-
flammatory response or acute phase reaction. Systemic
inflammatory response is a common reaction of the or-
ganism to any trauma. Nevertheless, the course and the
intensity of the systemic inflammatory response can be
influenced by many other factors. Age, obesity, comor-
bidities and smoking are preoperative factors stimulating
the systemic inflammatory response [23]. Systemic in-
flammatory response markers can be influenced by post-
operative complications yet, on the contrary, no impact
of the anaesthesia type on the postoperative CRP levels
was proved [24, 25]. Cortisol, IL-6, white blood cell
count (WCC) and CRP belong to the most frequently
studied systemic inflammatory response markers. Only
IL-6 and CRP, however, allow for differentiating the
relevance and the intensity of the systemic inflammatory
response caused by surgical trauma [26]. Several au-
thors have already published results of the systemic
Table 4 Results of monitoring markers
Cholecystectomy Hernia surgery
Median (IQR) p-value Median (IQR) p-value
Fbg (g/l) Fbg* 3.56 (3.17–3.90) 3.45 (3.05–3.95)
Fbg† 4.16 (3.66–4.66) p*† < 0.001 4.37 (3.71–5.09) p*† < 0.001
Fbg‡ 3.63 (3.25–4.01) p*‡ = 0.002 3.58 (3.20–4.22) p*‡ < 0.001
D-dimer (μg/l) D-dimer* 96.50 (57.00–139.25) 104.00 (62.00–161.00)
D-dimer† 409.00 (273.50–577.00) p*† < 0.001 318.50 (173.75–554.25) p*† < 0.001
D-dimer‡ 109.50 (67.00–155.50) p*‡ = 0.138 123.00 (71.50–216.00) p*‡ < 0.001
PLT (109/l) PLT* 230.00 (200.50–259.50) 212.00 (181.50–248.00)
PLT† 267.00 (234.50–303.50) p*† < 0.001 262.00 (225.00–312.00) p*† < 0.001
PLT‡ 227.00 (206.00–275.00) p*‡ = 0.042 216.00 (183.25–267.00) p*‡ = 0.088
F1 + F2 (nmol/l) F1 + 2* 0.17 (0.14–0.21) 0.18 (0.14–0.24)
F1 + 2† 0.24 (0.19–0.30) p*† < 0.001 0.26 (0.19–0.30) p*† < 0.001
F1 + 2‡ 0.21 (0.18–0.25) p*‡ = 0.002 0.23 (0.19–0.31) p*‡ < 0.001
Trf (g/l) Trf* 2.33 (2.08–2.65) 2.29 (2.00–2.55)
Trf† 2.42 (2.28–2.72) p*† = 0.057 2.36 (2.10–2.74) p*† = 0.074
Trf‡ 2.09 (1.89–2.42) p*‡ = 0.007 2.09 (1.96–2.35) p*‡ = 0.001
Orso (g/l) Oroso* 0.71 (0.62–0.81) 0.73 (0.60–0.88)
Oroso† 0.95 (0.82–1.07) p*† < 0.001 1.07 (0.85–1.18) p*† < 0.001
Oroso‡ 0.69 (0.63–0.85) p*‡ = 0.201 0.73 (0.57–0.86) p*‡ = 0.527
CRP (mg/l) CRP* 0.90 (0.45–2.10) 1.10 (0.44–2.60)
CRP† 3.47 (1.90–5.49) p*† < 0.001 3.85 (1.50–8.13) p*† < 0.001
CRP‡ 0.66 (0.33–1.57) p*‡ = 0.074 1.03 (0.57–2.01) p*‡ = 0.267
IL6 (pg/ml) IL6* 1.35 (0.98–2.06) 1.61 (1.17–2.91)
IL6† 2.48 (1.71–3.12) p*† = 0.002 3.30 (1.97–5.40) p*† < 0.001
IL6‡ 1.44 (0.97–1.93) p*‡ = 0.865 2.14 (1.23–2.82) p*‡ = 0.281
Notes: IQR – interquartile range; p-values – differences tested by Wilcoxon test; *before surgery; †7–10 days after surgery; ‡28–30 days after surgery; p*† – p-value
of the difference between measurement before surgery and 7–10 days after surgery; p*‡ – p-value of the difference between measurement before surgery and
28–30 days after surgery
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inflammatory response in patients after abdominal
hernia surgery in the early postoperative period
(within 48 h after surgery) [12–14, 27–30]. Only Akh-
tar et al. studied the systemic inflammatory response
in their patients after laparoscopic and open inguinal
hernia repair up to the 5th postoperative day [31].
Our results support the hypothesis that activated systemic
inflammatory response persists after open hernia surgery
even on postoperative day 7–10. Levels of inflammatory
markers (IL-6, CRP, α-1-acid glycoprotein) were statisti-
cally significantly elevated on postoperative day 7–10 as
compared to preoperative levels. However, a month after
the surgery, the inflammatory markers returned to the
preoperative levels, which reflect the subsided systemic
inflammatory response. Regarding cholecystectomy, lap-
aroscopic surgery is associated with lower systemic
inflammatory response compared to open cholecystec-
tomy [15–17]. More significant systemic inflammatory re-
sponses in patients after open cholecystectomy are related
to the magnitude of tissue trauma as a result of laparot-
omy. Di Vita et al. and Sista et al. measured the systemic
inflammatory response after open and laparoscopic
cholecystectomy till 7th and 12th postoperative day,
respectively. These authors noted that IL-6 and CRP
levels normalize by about the 6th or 7th postoperative
day [15, 32]. On the contrary, our results demonstrate
persisted systemic inflammatory response after laparo-
scopic cholecystectomy on postoperative day 7–10.
Significantly elevated inflammatory markers (IL-6,
CRP, α-1-acid glycoprotein) were proven at that time.
A month after the surgery, the systemic inflammatory
response had subsided and the inflammatory markers
dropped to baseline levels.
Postoperative hypercoagulability is an intrinsic re-
sponse to surgical trauma. In general, surgical trauma
induces a secondary postoperative thrombocytosis, ele-
vated levels of fibrinogen, prothrombin fragment F1 + 2
and D-dimer [33–35]. Postoperative hypercoagulability
and levels of coagulation markers can be modified by
the systemic inflammatory response, type of surgery,
postoperative complications and postoperative drug ad-
ministration. Dedej et al. described in patients after open
surgery a decrease in PLT levels 72 h postoperatively
[10]. PLT count decrease in the early postoperative
period has been explained by postoperative platelet
consumption and by postoperative VTE prophylaxis –
administration of unfractionated heparin or LMWH
[10]. Fibrinogen is a marker of activated coagulation
and fibrinogen also belongs to acute phase proteins.
Prothrombin fragment F1 + 2 corresponds with the
formed volume of thrombin and can be regarded as a
coagulation activity marker [36]. D-dimer forms dur-
ing the plasmin-induced breakdown of fibrin in the fi-
brinolytic pathway. D-dimer is considered a common
marker of coagulation activation, particularly a marker
of fibrinolysis. Elevated coagulation markers have
already been documented in the early postoperative
period in patients after cholecystectomy and hernia
surgery. Return of plasmatic fibrinogen to the preoperative
level was described by Di Vita et al. on postoperative day
7 after laparoscopic and open cholecystectomy as well
[15]. Patients after open cholecystectomy have higher
plasmatic prothrombin fragment F1 + 2 levels in the early
postoperative period compared to patients after laparo-
scopic cholecystectomy [34, 35]. However, there are no
data concerning hypercoagulability duration after surgery
for benign diseases. We observed interesting results in
both surgery groups of patients. Persisted hypercoagulabil-
ity was proven in hernia surgery group patients on post-
operative day 7–10. Statistically significantly elevated
levels of all coagulation markers (PLT count, levels of fi-
brinogen, prothrombin fragment F1 + 2 and D-dimer)
were measured. On postoperative day 28–30, significantly
elevated levels of fibrinogen, prothrombin fragment F1 + 2
and D-dimer were persistent in patients after hernia
surgery. Postoperative hypercoagulability persisted in
cholecystectomy group patients as well. All coagulation
markers were statistically significantly elevated compared
to preoperative baseline levels on postoperative day 7–10.
A month after the laparoscopic cholecystectomy decrease
and normalization of PLT count and D-dimer levels were
observed. However, persisted markers of activated coagu-
lation (fibrinogen, prothrombin fragment F1 + 2) were
proven in cholecystectomy group patients on 28th–30th
postoperative day. Prolonged elevation of D-dimer levels
and persisted activation of fibrinolysis in patients after
open hernia repair can be explained by more extensive
soft tissue trauma and the implantation of a foreign
body – mesh. The hypercoagulability status was
proven in our patients not only a week after but also,
surprisingly, a month after hernia surgery and laparo-
scopic cholecystectomy.
Conclusion
Despite the long persisting hypercoagulability in patients
after laparoscopic cholecystectomy and hernia surgery,
the prevalence of clinically apparent VTE was low in our
study population – 0.46 %. Our data support short-term
(in hospital) postoperative VTE prophylaxis in moderate
and high risk patients undergoing hernia repair or
cholecystectomy.
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